Turpaz: What Really Changed In Fragrance After Attractive Scent
Attractive Scent explains almost all of the non-organic step-up in Turpaz's fragrance division in 2025, but the bigger change sits elsewhere: moving to 100% ownership turned a premium Grasse asset into a group platform move, with fuller alignment and a clearer cash obligation.
What This Follow-Up Is Isolating
The main article already put Turpaz's acquisition liabilities at the center of the story. This follow-up isolates a different question: did Attractive Scent actually change the fragrance division itself, or did it mainly add more volume.
That matters because fragrance is not the group's largest division, but it is its highest-quality one on profitability. In 2025 it generated $49.4 million of revenue, about 18% of group sales, yet its operating margin stood at 26.0%, versus 19.3% in taste and 11.8% in specialty fine ingredients. If this division moves up a level, Turpaz is not only growing. It is changing its mix.
Two pictures need to be held at once. As of December 31, 2025, Turpaz still owned only 68.6% of Attractive Scent, and the company was consolidated only from July onward. So the annual report still does not show a full run-rate year under full ownership. But on February 2, 2026, the Put/Call mechanism was cancelled and Turpaz moved to an immediate purchase of the remaining 31.4%. That is the point where a good acquisition starts to look like platform-building.
The conclusion from the filings is sharp but not absolute: Attractive Scent has already shown that it can scale Turpaz's fragrance division without diluting its quality, but it has not yet fully proven that the division is structurally better on a full-year basis. The move to 100% ownership is the deeper economic change, because it turns a premium Grasse asset from a growth layer into part of the infrastructure Turpaz is trying to build its broader fragrance platform around.
Attractive Scent Explains Almost The Entire Step-Up, And That Is Encouraging
One number almost settles the "just bigger" question. Fragrance revenue rose 41.5% to $49.4 million, but organic growth in the division was only 8.6%. On a simple bridge from the 2024 base of $34.9 million, the non-organic increase in fragrance revenue during 2025 comes out at roughly $11.5 million.
Attractive Scent alone contributed $11.237 million of revenue from July through year-end. In other words, almost the entire non-organic layer of the fragrance division in 2025 appears to be Attractive Scent. That matters because it lets the reader test the quality of the deal almost directly through divisional numbers instead of getting lost in the consolidated story.
The quality test is where the read gets stronger. Fragrance operating profit rose to $12.84 million from $9.09 million, yet the division's operating margin stayed exactly at 26.0%. That is not trivial. A lower-quality acquired layer would normally dilute margin. That did not happen here. So the answer to whether Attractive merely made the division larger is no. It did make it larger, but it did so without weakening the economics of the group's highest-margin segment.
Still, the number does not prove everything. A 26.0% margin in 2025 versus 26.0% in 2024 is strong evidence of quality preservation, but not full proof of structural improvement. To argue that the division became better rather than simply larger while keeping quality intact, more than one partial year is needed.
The first stronger signal appears in the fourth quarter. Fragrance revenue in Q4 rose 87.6% to $15.7 million, while organic growth was 16.5%, and operating profit rose to $3.891 million from $1.804 million. Here the operating margin also improved, to 24.8% from 21.5%.
That still does not close the case, because it is only one quarter, but it does reinforce the idea that the deal may be doing more than adding volume. The direction at the end of the year already looks more premium in pace and in mix. So 2025 does not yet prove a complete step-up, but late 2025 does point clearly toward what Turpaz is trying to build.
What Turpaz Actually Bought
Attractive Scent does not read like another local fragrance blender folded into the group. It sits in Grasse in southern France, at the heart of the global perfume industry, and develops and markets perfume concentrates for fine fragrances, alongside personal care, cosmetics, air care and candles. It brings a production site, a development lab with leading perfumers, including one of the founders, and a sales center in Grasse itself. Its customer base stretches across Europe, the Middle East, Asia, Africa and South America.
That is exactly why management frames the Grasse presence as a premium product-development engine. This is not just one more geography. It is a move up the value ladder, toward fine fragrance, premium customers, and a part of the market where know-how, formulas and customer access can matter more than the factory itself.
The accounting says the same thing in a blunter language:
| Layer | What the filings show | Why it matters |
|---|---|---|
| Core activity | Fine fragrance alongside personal care, cosmetics, air care and candles | This is exposure to higher-value categories, not just more mass-market volume |
| Infrastructure | Production site, development lab and sales center in Grasse | Turpaz bought both industrial presence and development/commercial capability |
| Customer base | Europe, the Middle East, Asia, Africa and South America | The asset is not tied to one end-market only |
| 2025 contribution | $11.237 million of revenue and $1.348 million of net profit from July to year-end | The asset had immediate economic weight, not just strategic promise |
| Purchase price allocation | $11.557 million customer relationships, $7.923 million product formulas, $41.882 million goodwill versus $18.004 million identifiable net assets | Turpaz paid mainly for know-how, customer access and platform synergies, not for hard assets |
That is the most important way to read the deal. When the purchase-price allocation leans this hard on goodwill, customer relationships and formulas, Turpaz is effectively paying for more than standalone continuity. It is paying for a division-level platform lift.
That is why Attractive Scent looks like a real move up the value ladder. But for exactly the same reason, the burden of proof is higher. To justify $41.9 million of goodwill, it is not enough to keep Grasse performing well on its own. The asset has to improve the development capability, customer quality and strategic position of the broader fragrance division.
Cancelling The Put/Call Changed The Economics, Not Just The Form
This is where the real twist sits. At the July 2025 closing, Turpaz bought 68.6% of the equity, but the deal also included a reciprocal mechanism for the remainder. Ten percent of the shares became exercisable after one year, at a price based on Attractive Scent's performance in the preceding eight quarters, and was meant to be settled in Turpaz shares. Another 21.4% became exercisable after three years, at a price also based on the preceding eight quarters, and was meant to be settled in cash or Turpaz shares at the sellers' option.
So the original deal was never really "we bought 68.6% and will see later." From day one, it was built around the economics of eventually buying the rest.
That is especially visible in the purchase-price allocation. Out of a total purchase cost of $52.994 million, only $25.462 million was recorded as net cash paid at closing, while $27.532 million was recorded as a liability for a symmetrical put option on the minority shares and related adjustments. In plain terms, more than half of the acquisition cost was already carrying the minority question. February 2026 did not invent the economics of buying out the remainder. It turned a more formula-based and open-ended obligation into a clearer structure.
| Layer | Before the addendum | After the February 2, 2026 addendum | Why it matters | |-----|------|-------------| | Ownership | 68.6%, with a 31.4% minority layer | 100% ownership | The full economics of the asset move up to the group level | | Pricing mechanism | Two separate exercise windows, both tied to the prior 8 quarters | Fixed total consideration of EUR 20.1 million | Less formula uncertainty and less future pricing ambiguity | | Payment mix | 10% in shares, and 21.4% in cash or shares at the sellers' choice | EUR 7.3 million in shares, EUR 0.7 million in immediate cash, and EUR 12.1 million in cash on February 1, 2029 | Cleaner structure, but a more visible future cash leg | | Founders' role | Sellers and minority partners in the asset | Continue leading Attractive Scent and work to expand the broader fragrance division, global footprint and new markets | Alignment goes up, but so does execution burden |
This is not just cleaner paperwork. There are three real economic changes here.
The first is less uncertainty. A structure based on eight trailing quarters and on seller choice between cash and shares leaves Turpaz with less control over the eventual outcome. The addendum replaces that with a fixed headline number and a defined payment schedule.
The second is deeper alignment. Under the addendum, the founders are not only continuing to lead Attractive Scent. They are also meant to help expand the broader fragrance division, deepen the global footprint and develop new markets. That is no longer a mechanism that rewards them only for the asset they sold. It is a wider platform mandate.
The third is the shift from formula-based exposure to a visible capital-allocation item. The minority overhang is gone, but the EUR 12.1 million cash payment due on February 1, 2029 is explicit. The structure is cleaner. It is also more tangible.
What Still Needs To Be Proven
The temptation here is to jump too quickly to the conclusion that Attractive Scent has already upgraded the fragrance division. The evidence supports that only partly, not fully.
What has been proven? The asset appears to explain almost the entire non-organic step-up in the division. The division absorbed that step-up without diluting its 26.0% annual operating margin. And by Q4, the trajectory was already looking better on both pace and margin.
What has not yet been proven? The broader division has not yet fully re-rated on a full-year basis. The annual margin stayed at 26.0%, not above it. That means 2025 proves quality stability under scale, not a completed economic re-rating.
There is also another layer. The addendum turns Attractive's founders from managers of one asset into contributors to a wider platform. That is an advantage if Turpaz can leverage the know-how, formula base and Grasse access across the whole fragrance division. It is a burden if the wider mandate stretches focus and turns the best asset in the division into one more integration layer that has to be managed.
That is why the 2026 checkpoints are fairly clear:
| Checkpoint | Why it matters |
|---|---|
| Keeping the fragrance division at a mid-20s operating margin under a full year of Attractive consolidation | That is the core proof that the asset added more than revenue |
| Sustaining organic growth in fragrance once the initial consolidation effect annualizes | That is the test of whether the platform is genuinely stronger, not just bigger |
| Showing that the founders are expanding the broader fragrance division, not only keeping Attractive strong | That is what separates a good asset from a good platform |
| Managing the EUR 12.1 million 2029 cash leg within the group's capital allocation | Full ownership helps only if shareholder economics actually improve after the full bill is paid |
Bottom Line
Attractive Scent changed Turpaz's fragrance division more through platform quality than through an immediate full-year margin jump. In 2025 it almost single-handedly explains the non-organic growth layer in fragrance, and it did so without weakening the division's 26.0% annual operating margin. That is already a meaningful achievement.
But the bigger change arrived only in February 2026. Cancelling the Put/Call and moving to 100% ownership turned the deal from a premium asset with an active minority layer into a platform the group is trying to build its broader fragrance division around. That sharpens the upside because the full economics stay inside the group, but it also sharpens the price because the cash leg is visible and the execution mandate is wider.
So the right read for now is this: the division is probably better, and certainly broader, but the full proof is still ahead. If 2026 shows that fragrance margins hold under a full year of consolidation, and that Attractive Scent genuinely lifts the broader fragrance division rather than only itself, Turpaz will be able to argue that the move raised it up the value ladder. If not, it will turn out that the group bought a good asset, but not yet a clearly better platform.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.